J Gynecol Oncol.  2013 Jan;24(1):59-65. 10.3802/jgo.2013.24.1.59.

Establishment of a Korea HPV cohort study

Affiliations
  • 1Department of Preventive Medicine, The Catholic University of Korea College of Medicine, Seoul, Korea.
  • 2Department of Obstetrics and Gynecology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea.
  • 3Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea. jspark@catholic.ac.kr
  • 4Department of Pathology, Cheil General Hospital and Women's Healthcare Center, Kwandong University College of Medicine, Seoul, Korea.
  • 5Division of AIDS, Center for Immunology and Pathology, National Institute of Health, Korea Centers for Disease Control and Prevention, Cheongwon, Korea.
  • 6Department of Obstetrics and Gynecology, Chonnam National University Medical School, Gwangju, Korea.
  • 7Department of Obstetrics and Gynecology, Keimyung University Dongsan Medical Center, Daegu, Korea.
  • 8Department of Obstetrics and Gynecology, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.

Abstract

We have designed a five-year multicentre prospective cohort study in women who are both human papillomavirus (HPV)-positive with either atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous intraepithelial lesion (LSIL) of cervix. This study aimed to analyze the risk of developing a high-grade squamous intraepithelial lesion (HSIL) from either ASCUS or LSIL in HPV-positive women, so called 'progression' rate, to investigate differences in the progression rates according to HPV type-specific infection, and to evaluate the various factors associated with the persistence or clearance of HPV infection in the Korean population. At present, the study protocol composed of cervical cytology, HPV DNA testing, and questionnaire have been conducted actively since the first participant was enrolled in 2010. This study is the first nationwide Korea HPV cohort study. Our data will provide valuable information about not only the ambiguous cytology results of ASCUS and LSIL but also the effect of the specific HPV type and other various factors on the progression to HSIL. Finally, the results of our study will be helpful and applicable to determine the primary cervical cancer prevention strategies.

Keyword

Cervical intraepithelial neoplasms; Cohort studies; Human papillomavirus; Uterine cervical neoplasms

MeSH Terms

Cervical Intraepithelial Neoplasia
Cervix Uteri
Cohort Studies
Female
Human Papillomavirus DNA Tests
Humans
Korea
Uterine Cervical Neoplasms
Surveys and Questionnaires

Figure

  • Fig. 1 Schematic flow chart for the screening and follow-up. Women will be examined by repeat cytology and HPV testing every 6 months. Compared with the previous results of the HPV testing, the next follow-up would yield four possible kinds of change in HPV infection type and the result of cytology will be categorized into two groups (


Cited by  7 articles

Risk factors for cytological progression in HPV 16 infected women with ASC-US or LSIL: The Korean HPV cohort
Kyeong A So, Seon Ah Kim, Yoo Kyung Lee, In Ho Lee, Ki Heon Lee, Jee Eun Rhee, Mee Kyung Kee, Chi Heum Cho, Sung Ran Hong, Chang Sun Hwang, Mi Seon Jeong, Ki Tae Kim, Moran Ki, Soo Young Hur, Jong Sup Park, Tae Jin Kim
Obstet Gynecol Sci. 2018;61(6):662-668.    doi: 10.5468/ogs.2018.61.6.662.

A significant measure of HPV vaccine effectiveness in a high-risk population in Korea prior to a National Immunization Program
Suzanne Garland
J Gynecol Oncol. 2020;31(1):.    doi: 10.3802/jgo.2020.31.e32.

Status of HPV vaccination among HPV-infected women aged 20–60 years with abnormal cervical cytology in South Korea: a multicenter, retrospective study
Jaehyun Seong, Sangmi Ryou, Myeongsu Yoo, JeongGyu Lee, Kisoon Kim, Youngmee Jee, Chi Heum Cho, Seok Mo Kim, Sung Ran Hong, Dae Hoon Jeong, Won-Chul Lee, Jong Sup Park, Tae Jin Kim, Mee-Kyung Kee
J Gynecol Oncol. 2020;31(1):.    doi: 10.3802/jgo.2020.31.e4.

Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study
Yoon Park, Tae-Jin Kim, Chang-Sun Hwang, Chi Heum Cho, Dae Hoon Jeong, Seok Ju Seong, Jae-Kwan Lee, Sooyoung Hur, Mee-Kyung Kee, Jaehyun Seong, Moran Ki
J Gynecol Oncol. 2019;30(3):e50.    doi: 10.3802/jgo.2019.30.e50.

The Impact of High-Risk HPV Genotypes Other Than HPV 16/18 on the Natural Course of Abnormal Cervical Cytology: A Korean HPV Cohort Study
Kyeong A So, Mi Jung Kim, Ki-Heon Lee, In-Ho Lee, Mi Kyung Kim, Yoo Kyung Lee, Chang-Sun Hwang, Mi Seon Jeong, Mee-Kyung Kee, Chun Kang, Chi Heum Cho, Seok Mo Kim, Sung Ran Hong, Ki Tae Kim, Won-Chul Lee, Jong Sup Park, Tae Jin Kim
Cancer Res Treat. 2016;48(4):1313-1320.    doi: 10.4143/crt.2016.013.

Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028)
E Sun Paik, Myong Cheol Lim, Moon-Hong Kim, Yun Hwan Kim, Eun Seop Song, Seok Ju Seong, Dong Hoon Suh, Jong-Min Lee, Chulmin Lee, Chel Hun Choi
Cancer Res Treat. 2020;52(1):320-333.    doi: 10.4143/crt.2019.124.

Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study
Yoon Park, Tae-Jin Kim, Chang-Sun Hwang, Chi Heum Cho, Dae Hoon Jeong, Seok Ju Seong, Jae-Kwan Lee, Sooyoung Hur, Mee-Kyung Kee, Jaehyun Seong, Moran Ki
J Gynecol Oncol. 2019;30(3):.    doi: 10.3802/jgo.2019.30.e50.


Reference

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Globocan 2008: cancer incidence and mortality worldwide. 2010. Lyon: International Agency for Research on Cancer.
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012. 62:10–29.
3. Korean Cancer Registration and Statistics. Cancer incidence and death, 2009 [Internet]. c2012. cited 2012 Dec 10. Goyang: Korea Cancer Registration and Statistics, National Cancer Center;Available from: http://ncc.re.kr/manage/manage03_033_view.jsp?bbsnum=209&hSelSearch=&hTxtKeyword=&current_page=1&cd=null.
4. Kim JY, Nam BH, Lee JA. Is human papillomavirus genotype an influencing factor on radiotherapy outcome? Ambiguity caused by an association of HPV 18 genotype and adenocarcinoma histology. J Gynecol Oncol. 2011. 22:32–38.
5. Castellsague X. Natural history and epidemiology of HPV infection and cervical cancer. Gynecol Oncol. 2008. 110:S4–S7.
6. Alvarez RD, Wright TC. Optical Detection Group. Effective cervical neoplasia detection with a novel optical detection system: a randomized trial. Gynecol Oncol. 2007. 104:281–289.
7. Pothisuwan M, Pataradool K, Tangjitgamol S, Srijaipracharoen S, Manusirivithaya S, Thawaramorn T. Visual inspection with acetic acid for detection of high grade lesion in atypical squamous cells and low grade squamous intraepithelial lesions from cervical Pap smear. J Gynecol Oncol. 2011. 22:145–151.
8. Dunn TS, Burke M, Shwayder J. A "see and treat" management for high-grade squamous intraepithelial lesion pap smears. J Low Genit Tract Dis. 2003. 7:104–106.
9. Cox JT, Schiffman M, Solomon D. ASCUS-LSIL Triage Study (ALTS) Group. Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol. 2003. 188:1406–1412.
10. Reid R, Scalzi P. Genital warts and cervical cancer VII An improved colposcopic index for differentiating benign papillomaviral infections from high-grade cervical intraepithelial neoplasia. Am J Obstet Gynecol. 1985. 153:611–618.
11. Kelsey JL, Whittemore AS, Evans AS, Thompson WD. Methods in observational epidemiology. 1996. 2nd ed. New York: Oxford University Press.
12. Wheeler CM, Hunt WC, Schiffman M, Castle PE. Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study Group. Human papillomavirus genotypes and the cumulative 2-year risk of cervical precancer. J Infect Dis. 2006. 194:1291–1299.
13. Pretorius RG, Peterson P, Azizi F, Burchette RJ. Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less. Am J Obstet Gynecol. 2006. 195:1260–1265.
14. Chen EY, Tran A, Raho CJ, Birch CM, Crum CP, Hirsch MS. Histological 'progression' from low (LSIL) to high (HSIL) squamous intraepithelial lesion is an uncommon event and an indication for quality assurance review. Mod Pathol. 2010. 23:1045–1051.
15. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol. 1993. 12:186–192.
16. Walker JL, Wang SS, Schiffman M, Solomon D. ASCUS LSIL Triage Study Group. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS). Am J Obstet Gynecol. 2006. 195:341–348.
17. Hildesheim A, Herrero R, Castle PE, Wacholder S, Bratti MC, Sherman ME, et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer. 2001. 84:1219–1226.
18. Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol. 2001. 25:884–891.
19. Stankiewicz E, Prowse DM, Ng M, Cuzick J, Mesher D, Hiscock F, et al. Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS One. 2011. 6:e17517.
20. Li Y, Wang F, Xu J, Ye F, Shen Y, Zhou J, et al. Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol. 2011. 224:484–495.
21. Abba MC, Villaverde LM, Gomez MA, Dulout FN, Laguens MR, Golijow CD. The p53 codon 72 genotypes in HPV infection and cervical disease. Eur J Obstet Gynecol Reprod Biol. 2003. 109:63–66.
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr